SOFRAMYCIN NASAL SPRAY 0.05 MG — DIN 02224860
GRAMICIDIN : 0.05 MG FRAMYCETIN SULFATE : 12.5 MG PHENYLEPHRINE HYDROCHLORIDE : 2.5 MG · SEARCHLIGHT PHARMA INC · SPRAY · wholesale supply in Canada
Health Canada status: MARKETED
What is SOFRAMYCIN NASAL SPRAY?
SOFRAMYCIN NASAL SPRAY 0.05 MG contains GRAMICIDIN : 0.05 MG FRAMYCETIN SULFATE : 12.5 MG PHENYLEPHRINE HYDROCHLORIDE : 2.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02224860, held by SEARCHLIGHT PHARMA INC, supplied as SPRAY for NASAL administration. Health Canada currently lists it as marketed, status dated 10-Feb-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SOFRAMYCIN NASAL SPRAY used for?
Treatment of bacterial infections of the nose (rhino-sinusitis), skin (pyoderma, impetigo, infected burns/eczema), and eyes (conjunctivitis, blepharitis) caused by susceptible organisms.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Phenylephrine cost around the world?
Phenylephrine is listed on 6 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Greece publishes a producer price (ex-factory); Iceland publishes a max wholesale; Lebanon publishes a public price (USD, Decision 119/1). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 2 | 15 | USD███.██ |
| South Africa | single exit price | 5 | 5 | ZAR███.██ |
| Greece | producer price (ex-factory) | 3 | 3 | EUR███.██ |
| Iceland | max wholesale | 2 | 3 | ISK███.██ |
| United Kingdom | hospital | 2 | 2 | GBP███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
29 pack listings across 15 brand entries and 6 price bases, refreshed 03 Sep 2026. Ranges span every Phenylephrine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Phenylephrine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
7 holders have a Canadian DIN containing Phenylephrine, across 7 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SEARCHLIGHT PHARMA INC | 1 | 1 | SOFRAMYCIN NASAL SPRAY | Sourceable in Canada |
| BAYER INC CONSUMER CARE | 1 | 0 | NEO-SYNEPHRINE NASAL SPRAY | No marketed DIN |
| FOUNDATION CONSUMER BRANDS, LLC | 1 | 0 | DRISTAN NASAL MIST | No marketed DIN |
| HOECHST ROUSSEL CANADA INC. | 1 | 0 | SOFRAMYCIN NASAL SPRAY | No marketed DIN |
| ROUSSEL CANADA INC. | 1 | 0 | SOFRAMYCIN NASAL SPRAY | No marketed DIN |
| STERLING WINTHROP INC. | 1 | 0 | NEO SYNEPHRINE NASAL SPRAY | No marketed DIN |
| WYETH CONSUMER HEALTHCARE INC. | 1 | 0 | DRISTAN MENTHOLATED NASAL SPRAY | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.05 MG |
|---|---|
| Dosage form | SPRAY |
| Route | NASAL |
| Pack configuration (monograph) | Nasal Spray: 15 mL pump. Skin Ointment: 15 g tube. Eye Drops: 8 mL bottle. Sterile Eye Ointment: 5 g tube. |
| Storage | Store between 15°C and 30°C. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Phenylephrine |
|---|---|
| ATC code | R01AB01 |
| AHFS class | 52:32.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02224860 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2224860 |
| Brand name | SOFRAMYCIN NASAL SPRAY |
| Generic / active ingredient | GRAMICIDIN : 0.05 MG FRAMYCETIN SULFATE : 12.5 MG PHENYLEPHRINE HYDROCHLORIDE : 2.5 MG |
| Market authorization holder | SEARCHLIGHT PHARMA INC |
| Health Canada schedule | Prescription |
| ATC code | R01AB01 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R01AB |
| Current status | MARKETED |
| Status date | 10-Feb-2023 |
| Original market date | 2001-05-04 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Nasal: 2 sprays/nostril every 4h (max 6x/day). Skin: Apply 2-4x daily. Drops: 1-2 drops every 1-2h or 3-4x daily. Eye Ointment: 2-3x daily or at bedtime.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to ingredients/aminoglycosides. Nasal Spray: MAO inhibitors, narrow angle glaucoma, rhinitis sicca, children <2 years.
Warnings and precautions
Do not exceed recommended dosage. Prolonged use may cause rebound congestion. Risk of development of drug-resistant bacteria if used inappropriately.
Is Phenylephrine in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 7 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| DRISTAN MENTHOLATED NASAL SPRAY | 0.2 % | SPRAY | WYETH CONSUMER HEALTHCARE INC. | CANCELLED POST MARKET | 01929321 |
| DRISTAN NASAL MIST | 0.5 % | SPRAY | FOUNDATION CONSUMER BRANDS, LLC | CANCELLED POST MARKET | 01929313 |
| NEO SYNEPHRINE NASAL SPRAY | .1 % | SPRAY | STERLING WINTHROP INC. | CANCELLED POST MARKET | 01928538 |
| NEO-SYNEPHRINE NASAL SPRAY | .1 % | SPRAY | BAYER INC CONSUMER CARE | CANCELLED POST MARKET | 02150565 |
| SOFRAMYCIN NASAL SPRAY | 2.5 MG | SPRAY | ROUSSEL CANADA INC. | CANCELLED POST MARKET | 00173584 |
| SOFRAMYCIN NASAL SPRAY | 2.5 MG | SPRAY | HOECHST ROUSSEL CANADA INC. | CANCELLED POST MARKET | 01987690 |
2 · Same class — other molecules in ATC R01AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Phenylephrine | DRISTAN MENTHOLATED NASAL SPRAY · DRISTAN NASAL MIST · NEO SYNEPHRINE NASAL SPRAY · NEO-SYNEPHRINE NASAL SPRAY · +1 more | 7 | 1 | Yes |
| Ephedrine | BALMINIL NASAL OINTMENT · NASAL JELLY THUNA'S · RHINO-VACCIN | 3 | 0 | Not in Canada |
| Naphazoline | RHINO MEX | 1 | 0 | Not in Canada |
| Oxymetazoline | COOLING MENTHOL NASAL SPRAY | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R01AD | Beclomethasone · Budesonide · Ciclesonide · Flunisolide · Fluticasone · +5 more | 55 | 24 |
| R01AA | Ephedrine · Oxymetazoline · Phenylephrine · Xylometazoline | 76 | 18 |
| R01AX | Combinations · Ipratropium Bromide · Various | 42 | 4 |
| R01AC | Cromoglicic Acid · Levocabastine | 6 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is SOFRAMYCIN NASAL SPRAY called?
The same molecule, Phenylephrine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Phenylephrine Minims | Latin | Iceland |
| Neosynephrin Pos | Latin | Iceland |
| Phenylephrine Covan | Latin | South Africa |
| PHENYLEPHRINE HYDROCHLORIDE | Latin | Lebanon |
| Respinol Elixir | Latin | South Africa |
| Rinol | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.